BOSTON, Jan. 5 /PRNewswire-FirstCall/ -- Perceptive Informatics, the industry's leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (Nasdaq: PRXL), today announced that it has entered into a license agreement with the EuroQoL Group. The license allows Perceptive to provide EQ-5D, a standardized instrument to measure health-related quality of life outcomes, through its Electronic Patient Reported Outcomes (ePRO) solution in an Interactive Voice Response (IVR) format. Perceptive Informatics is among the first organizations in the industry to offer the EQ-5D instrument in an ePRO-IVR format.
The agreement provides clinical study sponsors the ability to collect health-related quality of life patient reported outcomes data via the telephone, using Perceptive's ePRO solution in an IVR format. With 83 official language versions of EQ-5D, the instrument can be used in a wide array of geographies for global clinical programs. EQ-5D is a non-disease specific instrument, making it applicable to a wide range of health conditions and treatments. The instrument allows for easy completion of required data by study participants. It provides a descriptive profile and a single index value for a particular health status.
"The use of electronic patient reported outcomes in clinical trials has
grown rapidly, especially as ePRO data, which has been increasingly accepted
by regulators, has expanded beyond efficacy data to include safety,
inclusion/exclusion, and medication compliance data. As sponsors are now using
ePRO for major therapeutic areas across phases of trials, our goal is to offer
more value to clients in this important component of an overall eClinical
platform," said Steve Kent, President of Perceptive Informatics. "We are
pleased to incorporate EQ-5D into our ePRO solution, workin
|SOURCE PAREXEL International Corporation|
Copyright©2009 PR Newswire.
All rights reserved